Amicus Therapeutics
FOLD
#3209
Rank
C$6.18 B
Marketcap
C$19.71
Share price
0.00%
Change (1 day)
54.12%
Change (1 year)

Market capitalization of Amicus Therapeutics (FOLD)

Market cap: C$6.18 Billion

As of March 2026 Amicus Therapeutics has a market cap of C$6.18 Billion. This makes Amicus Therapeutics the world's 3209th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Amicus Therapeutics from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026C$6.18 B2.53%
2025C$6.03 B46.18%
2024C$4.12 B-25.18%
2023C$5.51 B18.57%
2022C$4.65 B13.49%
2021C$4.10 B-46.54%
2020C$7.67 B136.12%
2019C$3.24 B31.47%
2018C$2.47 B-17.84%
2017C$3.00 B216.45%
2016C$0.95 B-43.5%
2015C$1.68 B82.35%
2014C$0.92 B495.1%
2013C$0.15 B17.21%
2012C$0.13 B9.08%
2011C$0.12 B-25.21%
2010C$0.16 B71.19%
2009C$94.7 M-56.1%
2008C$0.21 B-9.52%
2007C$0.23 B

End of Day market cap according to different sources

On Mar 14th, 2026 the market cap of Amicus Therapeutics was reported to be:

C$6.18 Billion
by Nasdaq info icon info icon
C$6.18 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novo Nordisk
NVO
C$232.19 B 3,651.80%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Biogen
BIIB
C$36.54 B 490.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$146.68 B 2,270.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
C$0.98 B-84.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C$0.80 B-87.07%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$15.43 B 149.39%๐Ÿ‡บ๐Ÿ‡ธ USA